Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DR26FSCT5
Awardee
Awarding agency
Obligated
$26,533

Award facts

Contract value 100% obligated
$26,532.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $26,532.96 delivery order to DMS Pharmaceutical Group Inc. on June 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for XTANDI 40 mg capsules (120-count units).

DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. Ultimate completion date is June 4, 2026. This is a firm fixed-price delivery order with no set-aside designation; it calls against the underlying PPV-G GEN V single-award indefinite delivery contract (SPE2DX), which carries a $499.999 billion ceiling and runs through December 31, 2036.

Quick answers

Who was awarded contract SPE2DR26FSCT5?

SPE2DR26FSCT5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2026.

How much is contract SPE2DR26FSCT5 worth?

The government has obligated $26,533 on SPE2DR26FSCT5.

Is contract SPE2DR26FSCT5 an order under another contract?

Yes. SPE2DR26FSCT5 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.

Was contract SPE2DR26FSCT5 competed?

The extent of competition for SPE2DR26FSCT5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award